Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

Pharming Q4 EPS $0.00 Up From $(0.02) YoY, Sales $81.20M Up From $54.62M YoY

Author: Benzinga Newsdesk | March 14, 2024 02:07am
Pharming (NASDAQ:PHAR) reported quarterly earnings of $0.00 per share. This is a 120 percent increase over losses of $(0.02) per share from the same period last year. The company reported $81.20 million in sales this quarter. This is a 48.66 percent increase over sales of $54.62 million the same period last year.

Posted In: PHAR

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist